In the present study we used IL-6 knockout mice (IL-6KO) to evaluate the ro
le of IL-6 in the inflammatory response caused by injection of carrageenan
into the pleural space. Compared with carrageenan-treated IL-6 wild-type (I
L-6WT) mice, carrageenan-treated IL-6KO mice exhibited a reduced degree of
pleural exudation and polymorphonuclear cell migration. Lung myeloperoxidas
e activity and lipid peroxidation were significantly reduced in IL-6KO mice
compared with those in IL-6WT mice treated with carrageenan. Immunohistoch
emical analysis for nitrotyrosine and poly(A)DP-ribose polymerase revealed
a positive staining in lungs from carrageenan-treated IL-6WT mice. No posit
ive staining for nitrotyrosine or PARS was found in the lungs of the carrag
eenan-treated IL-6KO mice. Staining of lung tissue sections obtained from c
arrageenan-treated IL-6WT mice with an anti-cyclo-oxygenase-2 Ab showed a d
iffuse staining of the inflamed tissue. Furthermore, expression of inducibl
e nitric oxide synthase was found mainly in the macrophages of the inflamed
lungs from carrageenan-treated IL-6WT mice. The intensity and degree of th
e staining for cyclo-oxygenase-2 and inducible nitric oxide synthase were m
arkedly reduced in tissue sections obtained from carrageenan-treated IL-6KO
mice. Most notably, the degree of lung injury caused by carrageenan was al
so reduced in IL-6KO mice. Treatment of IL-6WT mice with anti-IL-6 (5 mu g/
day/mouse at 24 and 1 h before carrageenan treatment) also significantly at
tenuated all the above indicators of lung inflammation. Taken together, our
results clearly demonstrate that IL-6KO mice are more resistant to the acu
te inflammation of the lung caused by carrageenan injection into the pleura
l space than the corresponding WT mice.